Epidermolysis Bullosa Clinical Trials

A listing of Epidermolysis Bullosa medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 15 clinical trials
A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa (DEFI-RDEB)

, adolescents, and adults with Recessive Dystrophic Epidermolysis Bullosa. Funding Source - FDA OOPD

  • 57 views
  • 03 Mar, 2022
  • 5 locations
Rigosertib in Patients With Recessive Dystrophic Epidermolysis Bullosa Associated SCC

This pilot trial studies how rigsertib sodium works in treating patients with Recessive Dystrophic Epidermolysis bullosa (RDEB) with locally advanced Squamous Cell Carcinoma (SCC). Rigosertib

  • 0 views
  • 08 Sep, 2021
  • 1 location
MT2015-20: Biochemical Correction of Severe EB by Allo HSCT and Serial Donor MSCs

identical, mismatched or haploidentical) or matched unrelated donor for the biochemical correction of severe epidermolysis bullosa (EB).

ejection fraction
thymoglobulin
mycophenolate mofetil
cyclophosphamide
fludarabine
  • 195 views
  • 25 Mar, 2022
  • 1 location
Study of Cellutome System for Treatment of Individual Lesions in EB Pts

Few but persistent wounds often remain even after successful hematopoietic cell transplantation for systemic genodermatosis epidermolysis bullosa (EB). The investigators propose local wound

dystrophic epidermolysis bullosa
stem cell transplantation
hepatitis b
cytopenias
  • 105 views
  • 03 Mar, 2022
  • 1 location
  • 0 views
  • 18 Apr, 2022
  • 3 locations
Injections of Botulinic Toxin in Plantar Lesions of Localized Epidermolysis Bullosa Simplex (EBTox)

The investigators hypothesize that palmar injections of botulinic toxin, via an inhibition of the sudation, would limit the occurrence of blisters in localized epidermolysis bullosa simplex

anesthesia
epidermolysis bullosa simplex
  • 186 views
  • 27 Feb, 2022
  • 3 locations
A Long-term Treatment With B-VEC for Dystrophic Epidermolysis Bullosa

Epidermolysis Bullosa (DEB). Participants will be dosed weekly with the topical B-VEC therapy. The primary endpoint will be to assess long term safety and tolerability of the topical gene therapy. The study is

dystrophic epidermolysis bullosa
  • 5 views
  • 19 Jun, 2021
  • 6 locations
Vitamin D Status and Bone Metabolism Status in Children With Congenital Epidermolysis Bullosa

osteopenia and osteoporosis in children with congenital epidermolysis bullosa.

deficiency
osteopenia
osteoporosis
malnutrition
vitamin d
  • 0 views
  • 27 Dec, 2021
  • 1 location
Pregabalin Treatment for RDEB Pain and Itch

Recessive dystrophic epidermolysis bullosa (RDEB) patients' quality of life is severely affected by neuropathic pain and itch, which have recently been demonstrated to be secondary to skin small

epidermolysis bullosa
pregabalin
neuropathy
dystrophic epidermolysis bullosa
neuropathic pain
  • 72 views
  • 19 Jun, 2021
  • 1 location
Rigosertib for RDEB-SCC

Epidermolysis bullosa (EB) is a heritable skin disease characterized by marked fragility of epithelialized tissue with blistering in skin and mucous membranes following the slightest mechanical

cetuximab
dermatological disease
cytotoxic chemotherapy
carboplatin
rigosertib
  • 117 views
  • 03 Mar, 2022
  • 1 location